Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Abstract
No abstract available
Funding Information
  • National Cancer Institute (U10CA21661, U10CA180822, U10 CA37422, U24CA180803)

This publication has 22 references indexed in Scilit: